Takeo Minaguchi

9PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 09, 2026
Impact of prior olaparib use on subsequent platinum-based therapy in recurrent ovarian cancer.

Kaori Ono, Yusuke Kobayashi, Ayumi Shikama

|Jan 09, 2026
Utility of iRECIST for evaluating treatment efficacy in patients receiving immune checkpoint inhibitors.

Genta Irie, Yusuke Kobayashi, Ayumi Shikama

|May 26, 2023
Preoperative Venous Thromboembolism Screening and Postoperative Selective Anticoagulant Therapy Effectively Prevents Postoperative Symptomatic Venous Thromboembolism in Gynecological Malignancies: A 15-Year, Single-Center Study.

Nobutaka Tasaka, Takeo Minaguchi, Narushi Iwata

|Apr 30, 2022
Differential roles of the Wip1-p38-p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas.

Chenyang Xu, Takeo Minaguchi, Nan Qi

|Mar 10, 2020
Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer.

Nobutaka Tasaka, Takeo Minaguchi, Yoshihiko Hosokawa

|Feb 19, 2020
PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas.

Shuang Zhang, Takeo Minaguchi, Chenyang Xu

Pageof 2

Frequent Collaborators

4 joint publications

Toyomi Satoh

3 joint publications

Takuya Kuboya

3 joint publications

Sari Nakao

3 joint publications

Kaori Takeuchi